LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Moore, Derek G.; Turner, John J.D.; Goodwin, J.E.; Fulton, S.E.; Singer, L.T.; Parrott, A.C. (2011)
Publisher: John Wiley & Sons
Languages: English
Types: Part of book or chapter of book
Subjects:

Classified by OpenAIRE into

mesheuropmc: mental disorders, psychological phenomena and processes
Review of preliminary evidence of the impact of MDMA and Methamphetamine on the developing infant
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Aguirre, N., Barrionuevo, M., Lasheras, B., & Del Rio, J. (1998). The role of dopaminergic systems in the perinatal sensitivity to 3,4- methylenedioxymethamphetamine-induced neurotoxicity in rats. Journal of Pharmacology and Experimental Therapeutics, 286(3), 1159-1165.
    • Allott, K., & Redman, J. (2007). Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neuroscience and Biobehavioral Reviews, 31(3), 327-347.
    • Arria, A. M., Derauf, C., LaGasse, L. L., Grant, P., Shah, R., Smith, L., et al. (2006). Methamphetamine and other substance use during pregnancy: Preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study. Maternal and Child Health Journal, 10(3), 293-302.
    • Barr, A. M., Panenka, W. J., MacEwan, W., Thornton, A. E., Lang, D. J., Honer, W. G., et al. (2006). The need for speed: an update on methamphetamine addiction. Journal of Psychiatry & Neuroscience, 31(5), 301-313.
    • Ben Hamida, S., Plute, E., Cosquer, B., Kelche, C., Jones, B. C., & Cassel, J. C. (2008). Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects. Psychopharmacology, 197(1), 67-82.
    • Billing L, Eriksson M, Steneroth G, Zetterstrom R. Preschool children of amphetamine-addicted mothers. I. Somaticand psychomotor development. Acta Paediatr Scand 1985;74:179-84.
    • Billing L, ErikssonM, Steneroth G, Zetterstrom R. Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abus Negl 1988;12:503-7.
    • Billing, L., Eriksson, M., Jonsson, B., Steneroth, G., & Zetterstrom, R. (1994). The Influence of Environmental-Factors on Behavioral-Problems in 8-Year-Old Billing, L., Eriksson, M., Larsson, G., & Zetterstrom, R. (1980). Amphetamine Addiction and Pregnancy .3. One Year Follow-up of the Children - Psychosocial and Pediatric Aspects. Acta Paediatrica Scandinavica, 69(5), 675-680.
    • Broening, H.W., Morford, L.L., Inman-Wood, S.L., Fukumura, M., Vorhees, C.V. (2001). 3,4-Methylenedioxymethamphetamine (Ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. Journal of Neuroscience, 21(9), 3228-3235.
    • Bronson, M.E., Jiang, W, Clark, C.R., DeRuiter, J. (1994). Effects of designer drugs on the chicken embryo and 1-day-old chicken. Brain Research Bulletin, 34(2), 143-150.
    • Buchert, R., Thomasius, R., Nebeling, B., Petersen, K., Orbrocki, J., Jenicke, L., Wilke, F., Wartberg, L., Zapletalove, P., Clausen, M. (2003). Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. Journal of Nuclear Medicine, 44, 375-384.
    • Chang, L., Smith, L. M., LoPresti, C., Yonekura, M. L., Kuo, J., Walot, I., et al. (2004). Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Research-Neuroimaging, 132(2), 95-106.
    • Colado, M.I., O'Shea, E., Granados, R., Misra, A., Murray, T.K., Green, A.R. (1997). A study of the neurotoxic effect of MDMA ('Ecstasy') on 5-HT neurons in the brains of mothers and neonates following administration of the drug during pregnancy. British Journal of Pharmacology, 121(4), 827-833.
    • Connor, T.J. Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system. Immunology. 2004 Apr;111(4):357-67.
    • Curran, H.V. & Robjant, K. (2006) Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy. J Psychopharmacol. 20, 425-31.
    • De Win, M.M., Reneman, L., Reitsma, J.B., den Heeten, G.J., Booij, J., van den Brink, W. (2004). Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose and gender. Psychopharmacology, 173, 376-382.
    • Dixon, S.D., et al. (1989) Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. J Pediatr, 115, 770-8.
    • Dluzen, D.E., & Liu, B.(2008) Gender differences in methamphetamine use and responses: a review. Gend Med, 5, 24-35.
    • Eriksson, M., Billing, L., Steneroth, G., & Zetterstrom, R. (1989). Health and Development of 8-Year-Old Children Whose Mothers Abused Amphetamine During Pregnancy. Acta Paediatrica Scandinavica, 78(6), 944-949.
    • Fergusson, D. M., Horwood, L. J., & Northstone, K. (2002). Maternal use of cannabis and pregnancy outcome. Bjog-an International Journal of Obstetrics and Gynaecology, 109(1), 21-27.
    • Fisk, J.E., Montgomery, C., Wareing, M., Murphy, P.N. (2005). Reasoning deficits in ecstasy (MDMA) polydrug users. Psychopharmacology 181, 550-559.
    • Fox, H., Parrott, A.C., Turner, J.J.D. (2001). Ecstasy/MDMA related cognitive deficits: a function of dosage rather than awareness of problems. Journal of Psychopharmacology, 15, 273-281.
    • Fox, H.C., McLean, A., Turner, J.J.D., Parrott, A.C., Rogers, R., Sahakian, B.J. (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology,162, 203-214.
    • Freedman, R.R., Johnson C.E., Tancer, M.E. (2005). Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 183, 248-256
    • Green, A.R., Mechan, A.O., Elliott, J.M., O'Shea, E., Colado, M.I. (2003). The pharmacology and clinical pharmacology of 3,4-methylene-dioxy-methamphetamine (MDMA, “ecstasy”). Pharmacological Reviews, 55, 463-508
    • Ho, E., Karimi-Tabesh, L., Koren, G. (2001). Characteristics of pregnant women who use ecstasy (3,4-methylendioxymethamphetamine). Neurotoxicology and Teratology, 23, 561-567.
    • Iversen L (2006) Speed, Ecstasy, Ritalin: The Science of Amphetamines. OUP, Oxford.
    • Johnson, M.H. (2003). The development of human brain function. Biological Psychiatry, 54, 1312- 1316
    • Johnston, L.D., O'Malley, P.M., Bachman, J.G. (2001). Monitoring the future: National results on adolescent drug use. National Institute on Drug Abuse, U.S. Department of Health and Human Services, Washington, D.C.
    • Johnston, L.D., O'Mally, P.M., Brachman, J.G., & Schulenberg, J.F. (2005a). Monitoring the Future national survey results on drug use, 1975-2004: Volume II, College students and adults ages 19-45 (NIH Publication No. 05- 5728) Bethesda, MD: National Institute on Drug Abuse.
    • Johnston, L.D., O'Mally, P.M., Brachman, J.G., & Schulenberg, J.F. (2005b). Monitoring the Future national results on adolescent drug use: Overview and key findings, 2004. (NIH Publication No. 05-5726). Bethesda, MD: National Institute on Drug Abuse.
    • Kobeissy FH, Jeung JA, Warren MW, Geier JE, Gold MS.(2008) Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. Addict Biol.13,15-25.
    • Kokoshka, J. M., Metzger, R. R., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (1998). Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Research, 799(1), 78-83
    • Koprich, J.B., Chen, E.Y., Kanaan, N.M., Campbell, N.G., Kordower, J.H., Lipton, J.W.. (2003). Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behaviour, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicology and Teratology, 25(5), 509-517.
    • Lamers, C. T. J., Bechara, A., Rizzo, M., & Ramaekers, J. G. (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology, 20(2), 302-311.
    • Lester, B. M., & Tronick, E. Z. (2004). The Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) - Introduction. Pediatrics, 113(3), 631-631.
    • Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001). Gender differences in the subjective effects of MDMA. Psychopharmacology, 154(2), 161-168.
    • MacInnes, N., Handley, S.L., Harding, G.F.A. (2001). Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. Journal of Psychopharmacology, 15, 181-186.
    • Martinez, L.R., Mihu, M.R., Gácser, A., Santambrogio, L., Nosanchuk, J.D. (2009) Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis. Jul 1;200(1):131-41.
    • Mazer, C., Muneyyirci, J., Taheny, K., Raio, N., Borella, A., Whitaker-Azmitia, P. (1997). Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits. Brain Research, 760, 68-73.
    • McElhatton, P., Hedgely, C., Thomas, S. (2004). Congenital anomalies after prenatal ecstasy exposure. Proceedings of the British Pharmacological Society. National Teratology Information Service (NTIS) RDTC, Claremont Place, Newcastle, U.K.
    • McKetin, R., Kozel, N., Douglas, J., Ali, R., Vicknasingam, B., Lund, J., et al. (2008). The rise of methamphetamine in southeast and East Asia. Drug and Alcohol Review, 27(3), 220-228.
    • McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101(10), 1473-1478.
    • Meyer, J.S., Grande, M., Johnson, K., Ali, S.F. (2004). Neurotoxic effects of MDMA (“ecstasy”) administration to neonatal rats. International Journal of Developmental Neuroscience, 22, 261-271.
    • Milani, R., Parrott, A.C., Turner, J.J.D. & Fox, H.C.. (2004). Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. Addictive Behaviours, 29, 965-971.
    • Milani, R., Turner, J.J.D., Parrott, A.C., Parmar, R. (2000). Recreational drug use and psychobiological problems, collaborative UK/Italy study (5): Ecstasy (MDMA) polydrug findings. Journal of Psychopharmacology, 14(a15).
    • Milani, R.M., Parrott, A.C. Schifano F, et al. (2005). Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms. Human Psychopharmacology-Clinical And Experimental, 20 (4), 249-261.
    • Parrott, A.C. (2002). Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacology, Biochemistry, and Behavior 71, 837-844
    • Parrott, A.C. (2004). MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology, 50, 329-335
    • Parrott A.C. (2006). MDMA in humans: factors which influence the neuropsychobiological profiles of recreational Ecstasy users, the integrative role of bio-energetic stress. Journal of Psychopharmacology, 20, 147-163
    • Parrott, A.C., Milani, R., Parmar, R., Turner, J.J.D. (2001). Ecstasy polydrug users and other recreational drug users in Britain and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology, 159, 77-82.
    • Parrott, A.C., Sisk, E., Turner, J. (2000) Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug and Alcohol Dependence, 60, 105-110
    • Parrott, A.C., Young, L. (2005) Increased body temperature in recreational Ecstasy/MDMA users out clubbing and dancing, Journal of Psychopharmacology, 19, a26.
    • Rendell, P. G., Gray, T. J., Henry, J. D., & Tolan, A. (2007). Prospective memory impairment in "ecstasy" (MDMA) users. Psychopharmacology, 194(4), 497- 504.
    • Rodgers, J. (2000). Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology, 151, 19-24
    • Rodgers, J., Buchanan, T., Scholey, A.B., Heffernan, T.M., Ling, J., Parrott, A.C. (2003). Patterns of drug use and the influence of gender on self reports of memory ability in ecstasy users: a web based study. Journal of Psychopharmacology, 17, 379-386.
    • Scholey, A.B., Parrott, A.C., Buchanan, T., Heffernan, T., Ling, J., Rodgers, J. (2004). Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a www study. Addictive Behavior, 29, 743-752.
    • Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., et al. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review, 17(3), 275-297.
    • Shoblock JR, Sullivan EB, Maisonnueve IM, Glick S (2003) Neurochemical and behavioural differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology, 165, 359-369.
    • Singer, L.T., Linares, T.J., Ntiri, S., Henry, R. Minnes, S. (2004). Psychosocial profiles of older adolescent ecstasy users in the United States, Alcohol and Drug Dependence, 74, 245-252.
    • Skelton, M. R., Williams, M. T., & Vorhees, C. V. (2008). Developmental effects of 3 4-methylenedioxymethamphetamine: a review. Behavioural Pharmacology, 19(2), 91-111.
    • Smith, L. M., Chang, L., Yonekura, M. L., Grob, C., & Ernst, T. (2001). Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology, 57(2), 255-260.
    • Smith, L. M., LaGasse, L. L., Derauf, C., Grant, P., Shah, R., Arria, A., et al. (2008). Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicology and Teratology, 30(1), 20-28.
    • Smith, L., Yonekura, M. L., Wallace, T., Berman, N., Kuo, J., & Berkowitz, C. (2003). Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. Journal of Developmental and Behavioral Pediatrics, 24(1), 17-23.
    • Smith, L. M., LaGasse, L. L., Derauf, C., Grant, P., Shah, R., Arria, A., et al. (2006). The infant development, environment, and lifestyle study: Effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics, 118(3), 1149-1156.
    • Struthers JM, Hansen RL. Visual recognition memory in drug-exposed infants. J Dev Behav Pediatr 1992;13:108-11.
    • Tallóczy, Z., Martinez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., Mizushima, N., Nosanchuk, J.D., Goldstein, H., Loike, J., Sulzer, D., Santambrogio, L. (2008).Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 8;4(2):e28
    • Ter Bogt, T.F., Engels, R.C. (2005). "Partying" hard: party style, motives for and effects of MDMA use at rave parties. Substance Use and Misuse, 40, 1479- 1502.
    • Thomasius, R., Zapletalova, P., Petersen, K., Buchert, R., Andresen, B., Wartberg, L., et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Journal of Psychopharmacology, 20(2), 211-225.
    • Thompson, B. L., Levitt, P., & Stanwood, G. D. (2009). SCIENCE AND SOCIETY Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nature Reviews Neuroscience, 10(4), 303-U377.
    • Turner, J.J.D., Godolphin, M., Parrott, A.C. (1999). Cognitive task performance of current and former Ecstasy (MDMA) users. British Association for Psychopharmacology Annual Conference. Journal of Psychopharmacology, 13, a24.
    • United Nations Office on Drugs and Crime, World Drug Report (2004). Analysis,vol 1, United Nations Publication.
    • van Tonningen-van Driel, M.M., Garbis-Berkvens, J.M., Reuvers-Lodwijks, W.E. (1999). [Pregnancy outcome after Ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM)]. Nederlands Tijdschrift voor Geneeskunde., 143(1), 27-31.
    • Verheyden, S.L., Hadfield, J., Calin, T., Curran, H.V. (2002) Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology 161, 23-31.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
    63
    63%
  • No similar publications.

Share - Bookmark

Funded by projects

Cite this article